FDA Says Diabetic Foot Gel Could Cause Cancer

Law360, New York (March 28, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration is stepping up its investigations of a foot gel used by diabetics for leg wounds that may increase the risk of cancer and death, the agency said on Thursday.

The FDA said that a study of Johnson & Johnson Co.'s Regranex found that patients who had been prescribed the gel three or more times were more likely to get a fatal form of cancer.

Regranex, approved in 1997, is used by diabetes patients to help heal leg and foot wounds....
To view the full article, register now.